Conclusion:
The splice site mutation c.2189+1G>T in MERTK causes rod-cone 55 dystrophy with a distinct macular phenotype. The debris in the sub-neurosensory space resembles that in the Royal College of Surgeons (RCS) rat being the mertk animal model. Patients might therefore benefit from advances in gene therapy that were previously achieved in the RCS rat.
60
Mutations in the MERTK gene cause retinal dystrophies in humans as well as in animal models. [1] [2] [3] [4] [5] [6] [7] The gene product, a tyrosine kinase receptor, consists of an intracellular kinase domain, a transmembrane region, and an extracellular domain. 8;9 During the physiological renewal of photoreceptor outer segments, membrane discs are shed and phagocytised by the retinal pigment epithelium (RPE) cells. MERTK 70 plays a key role in this process by triggering photoreceptor outer segment ingestion. 10 Mutation in mertk causes spontaneous retinal degeneration due to impaired phagocytic activity of RPE cells in the Royal College of Surgeons (RCS) rat. 1 In this widely used animal model, shed membranes from photoreceptor outer segments 75 accumulate in the sub-neurosensory space, 11 and photoreceptor cells subsequently undergo apoptosis. 12 The retinal pathology of the RCS rat has been studied extensively, 11;13;14 and treatment strategies for retinal degenerations, including gene therapy, have been investigated. [15] [16] [17] Specifically, viral-mediated gene therapy as a treatment of patients with retinal dystrophy due to mutations in MERTK appears to be 80 feasible, since the introduction of the gene into the eyes of juvenile rats, which already display significant pathology, resulted in areas of near normal-appearing retina. 15 In 2000, Gal and co-workers identified human mutations in the MERTK gene in patients with recessively inherited panretinal dystrophy.
2 This was the first 85 conclusive evidence implicating RPE-mediated outer segment phagocytosis pathway in human retinal disease. Subsequently, other groups have also reported MERTK mutations in patients with panretinal dystrophies.
3;4;6;7 In order to select patients who might benefit from future gene-specific therapies, accurate phenotyping appears crucial.
Here, we present detailed characteristics of the ocular phenotype in eight members of a consanguineous Moroccan family previously described by our group segregating a splice site mutation in MERTK. 18 The mutation, c.2189+1G>T, results in skipping of exon 16 with a subsequent frameshift and predicted shortening of the protein to 696 residues (wildtype: 999 residues). Five out of six children carry the 95 mutation in homozygous state and developed cone rod dystrophy. The age of the patients ranged from five to 19 years, allowing an estimation of disease progression which is further substantiated by longitudinal data in a subset of affected siblings.
Methods 100
All family members underwent detailed clinical investigation including best-corrected visual acuity (VA), slit lamp examination, and stereoscopic funduscopy. Goldmann Germany). During acquisition of FAF images, the software allows to digitally enhanceimage contrast by assigning 255 gray values even if the difference between the lowest and the highest gray value is very low ("image normalization"). Absolute FAF intensity can not be analyzed quantitatively from images recorded with the cSLO. 20 However, the required setting of the signal detector allows a rough estimation of the FAF intensity, and when image normalization is deactivated, relative intensity within a 120 region of interest of a given image can be evaluated. All FAF images are composed of multiple averaged images resulting in an increased signal to noise ratio.
Additional high resolution spectral domain OCT imaging (Spectralis HRA-OCT, Heidelberg Engineering, Heidelberg, Germany) was performed in family members II:4 and II:5 who were available for a follow up examination two years later. 125
The study was conducted in adherence to the tenets of the Declaration of Helsinki and was approved by the Ethics Committee, University of Bonn.
Results
None of the family members had a significant history of systemic diseases or of 130 medication. Only the parents (being heterozygous) and the second youngest sibling (carrying the wild type allele homozygously) were unaffected (the pedigree is shown in supplementary Fig. 1 ). The epidemiological data are summarized in Table 1 . The findings of the individual examinations in family members with retinal disease were as follows:
• Visual acuity (Table 1) in the better eye was reduced to 20/50 in the two youngest siblings and to 20/100 in the oldest sister. In the fellow eye, VA was20/63 in the youngest to 20/400 in the oldest siblings. Two brothers were available for a follow up examination two years later. In II:4, visual acuity had deteriorated to 20/400 in the right eye and to 20/63 in the left eye. In II:5, it had decreased to 20/400 in the right eye and remained 20/50 in the left eye.
• Nystagmus was not observed in any of the affected family members. 160
• Goldmann kinetic perimetry (Fig. 1) was relatively well preserved for Goldmann III4e, but showed variable concentric constriction for the test stimulus I4e. Due to insufficient cooperation, perimetric examination was not possible in the two youngest brothers.
• Biomicroscopy: In all affected siblings, a posterior subcapsular cataract, vitreous 165 destructions and vitreous cells were present to different degrees. The retinal vessels were only mildly attenuated, and there was no significant optic disc pallor.
Ophthalmoscopy revealed increased reflectivity with a wrinkled appearance of the inner retina which was accentuated at the posterior pole ( Fig. 2A-D) . In the youngest patient (II:1), the macula showed white-yellowish small subretinal 170 deposits ( Fig. 2A) that showed increased FAF (see below). In the older siblings, a yellowish macular atrophy had developed that was most severe in the oldest affected patient (II:6) who, in addition, showed crystalline retinal deposits. There was apparent salt-like pigment mottling at the midperiphery in the three oldest siblings (Fig. 2E-G) . Only in patient II:6, there was focal intraretinal bone spicule-175 like pigment clumping in the outer periphery of the left eye (Fig 2G) .
At the follow up examination of II:4 and II:5 two years later, both showed progression of the retinal findings. In II:4, the atrophy had enlarged and a multitude of superficial retinal crystalline deposits were visible at the posterior pole, now resembling the findings in the eldest sibling (II:6) two years earlier.
There was now also few intraretinal pigment clumping surrounding peripheral retinal vessels. In II:5, small atrophic patches of the central retina had developed that were similar to the findings in II:4 in the baseline assessment.
• FAF-imaging (Fig. 3) (Fig. 3I,J) .
• OCT-imaging revealed thinning of the neurosensory retina that was mainly confined to the outer retina with a thinned outer nuclear layer and major alterations external to the external limiting membrane. Spectral domain OCT images were available from subjects II:4 and II:5 and revealed debris-like 195 material in the sub-neurosensory space. (Fig. 4) . The hyper-reflective border between inner and outer photoreceptor segments that usually is visible on spectral domain OCT-scans was absent. Underneath the preserved external limiting membrane there was debris-like material in the sub-neurosensory space.
Moreover, a peculiar wavelike appearance of the innermost neurosensory retina 200 was present correlating to the wrinkled appearance of the inner retina on funduscopy.
• ERG (Fig. 5) showed a marked reduction of the cone specific b-wave amplitudes and absence of the rod specific b-wave in the youngest sibling (Patient II-1). In all other affected siblings, scotopic and photopic ERG responses wereundistinguishable from noise. Recordings of unaffected family members were in agreement with normative data. ERG responses were consistently reproducible.
Discussion
This study describes the specific phenotype of a rod-cone dystrophy with macular 210 atrophy due to a recessive splice site mutation in MERTK. Five affected siblings at ages between five and 19 years were examined. Thus, the family provided a model to obtain quasi-longitudinal data of disease progression due to the c.2189+1G>T mutation in MERTK. The phenotype was indeed least severe in the youngest and most advanced in the oldest affected sibling, indicating progression of the disease 215 during the natural history. This was further substantiated by longitudinal data in II:4 and II:5 exhibiting definite disease progression.
Gal and co-workers screened MERTK in 328 DNA samples from patients with various retinal dystrophies and found three mutations in three individuals with autosomal recessive retinitis pigmentosa.
2 In these patients, poor vision and night 220 blindness were already present in childhood; however, the retinal phenotypes were not presented in detail. Two recent reports found further disease-associated MERTK mutations and characterized the retinal dystrophies of the respective patients: McHenry et al. described a female patient with severe early-onset rod-cone dystrophy and nystagmus. 4 Her fundus showed disc pallor, vessel narrowing, bull's-225 eye macular atrophy, bone spicule pigment in all quadrants, dense parafoveal pigmentation, and heavy RPE granularity throughout the fundus. The visual field was constricted concentrically and the ERG showed a complete loss of responses to all rod and cone stimuli. Tschernutter and co-workers screened 96 patients with retinal dystrophy and identified one novel frame-shifting deletion in MERTK causing retinitispigmentosa. 3 The researchers presented the first detailed clinical characterization of the retinal dystrophy associated with MERTK mutation in four affected members of a Middle Eastern family. As in the family presented herein, the patients reported first symptoms around the age of 10 years, and there was disease progression over time. 3 In a 46 year old family member, visual function was reduced to perception of 235 light. The phenotype of the family including FAF was very similar to our cases.
Interestingly, their patients also had relatively preserved peripheral visual fields and a relatively increased FAF signal in the central macula. These findings, together with the generally reduced FAF signal, might be characteristic for retinal dystrophies associated with MERTK mutations and could be useful to distinguish these patients 240 from other diseases such as RP or cone dystrophies due to other causative gene mutations. It appears that in MERTK-unrelated retinal dystrophies, FAF may show a well-defined ring of increased FAF that has no obvious correlate on fundus biomicroscopy. 21 Furthermore, the perimetric hallmark of RP are concentrically constricted visual fields. 245
However, the expressivity of the retinal dystrophy due to mutations in the MERTK gene appears to be variable. Initial reports on human MERTK mutations 2;4 described a more severe phenotype compared to the patients presented in our report and by Tschernutter and co-workers. Therefore, different MERTK mutations may be associated with different disease severity. However, as all mutations including the 250 one described herein are truncating, there is no obvious genotype-phenotype correlation with respect to the mutation type.
Royal college of surgeon rats show debris in the subretinal space, most likely due to the inability of the pigment epithelium to clear shed photoreceptor outer segments. 11;13 In two affected patients, spectral domain technology was used toobtain cross sectional high-resolution images of the retina. The decrease in retinal thickness, mainly due to atrophy in the outer retinal layers is in accordance with histological findings in RCS rats. Moreover, there appeared to be subneurosensory debris which most likely is analogous to the debris found in RCS rats. 11;13 This finding strongly supports the similar pathophysiology and biological consequence of the 260 panretinal dystrophy due to a MERTK mutation in the RCS rat and humans. It furthermore makes viral-mediated gene therapy a therapeutic option for affected patients, since gene therapy experiments yielded very successful results in the RCS rat. [15] [16] [17] Very recently, Bainbridge and co-workers reported promising results treating human panretinal dystrophies due to mutations in the RPE65 gene by subretinal 265 administration of recombinant adeno-associated virus vector. 22 Their findings certainly support the research efforts to establish gene therapy for retinal dystrophies due to loss-of-function mutations in retinal disease genes. Identifying patients for such therapeutic intervention may turn out to be challenging and specific phenotypes may be crucially important. Our study provides evidence suggesting that such 270 specific phenotypes can be identified especially by using multimodal retinal imaging techniques.
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The funding organizations had no influence on the study design, the collection, analysis, and interpretation of data, the writing of the report and in the decision to submit the paper for publication. In affected family members, disregarding the relatively increased FAF signals, the 410 overall FAF intensity was poor, and the acquisition settings had to be near the maximum sensitivity of the system. This is shown by recordings without image normalization of the left eyes of II:5 (additional four months after the recordings shown in (H)) and a male control subject of the same age, both having clear optical media (I,J). The laser power (excitation light) was constant, and images where 415 acquired in succession without changing the settings of the detector sensitivity. If the latter resulted in a desirable signal in the control subject, the signal in the patient with the MERTK mutation was very low (I). A detector sensitivity set to its maximum resulted in an apparently close to normal overall signal strength, however, the same setting showed strong overexposure in the normal control subject (J). This implies 420 that even such focal areas exhibiting a relative increase in FAF may indeed have a (sub-) normal FAF signal compared to normal. 
